Powder: -20℃ for 3 years | In solvent: -80℃ for 1 year
货源
新品
图文详情
LY-3475070 is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.